The importance of genomic copy number changes in the prognosis of glioblastoma multiforme

Neurosurgical Review

Volumn 27, Issue 1, 2004, Pages 58-64

  Arslantas, Ali ^a,b   Artan, Sevilhan ^a   Öner, Ülkü ^a   Müslümanoǧlu, Hamza ^a   Durmaz, Ramazan ^a   Cosan, Erhan ^a   Atasoy, Metin Ant ^a   Başaran, Nurettin ^a   Tel, Eşref ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Comparative genomic hybridization; Genomic imbalances; Glioblastoma multiforme

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SCREENING; CHROMOSOME 10; CHROMOSOME 12Q; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 7; CHROMOSOME DELETION; CHROMOSOME LOSS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE AMPLIFICATION; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GENE DOSAGE; GENETIC MARKERS; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS;

EID: 0742288368     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10143-003-0279-4     Document Type: Article

References (31)

1. Scott, JN, Rewcastle NB, Brasher PM, Fulton D, Hagen N, MacKinnon JA, Sutherland G, Cairncross JG, Forsyth P (1998) Long term glioblastoma multiforme survivors: a population based study. Can J Neurol Sci 25:197-201
2. Cooper GM (1997) The cell. Oxford University Press, New York
3. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavanee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225
4. Schmidt MC, Antweiler S, Urban N, Mueller W, Kuklik A, Meyer-Puttlitz B, Wiestler OD, Louis DN, Fimmers R, Von Deimling A (2002) Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol 61:321-328
5. Burger PC, Vollmer RT (1980) Histologic factors of prognostic significance in the glioblastoma multiforme. Cancer 46:1179-1186
6. Burger PC, Vogel FS, Green SB, Strike TA (1985) Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56:1106-1111
7. Jung V, Romeike FM, Henn W, Feiden W, Moringlane JR, Zang KD, Urbschat S (1999) Evidence of focal genetic microheterogenity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells. J Neuropathol Exp Neurol 58:993-999
8. Rey JA, Bello MJ, de Campos JM, Kusak ME, Moreno S (1987) Chromosomal composition of a series of 22 human low-grade gliomas. Cancer Genet Cytogenet 29:223-237
9. Bigner SH, Mark J, Burger PC, Mahaley MS, Bullar DE, Muhlbaier LH, Bigner DD (1988) Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 88:405-411
10. Brunner C, Jung V, Henn W, Zang KD, Urbschat S (2000) Comparative genomic hybridization reveals recurrent enhancements on chromosome 20 and in one case combined amplification sites on 15q24q26 and 20p11p12 in glioblastomas. Cancer Genet Cytogenet 121:124-127
11. Schröck E, Thiel G, Lozanova T, du Manoir S, Meffert M-C, Jauch A, Speicher MR, Nürnberg P, Vogel S, Janisch W, Donis-Keller H, Ried T, Witkowski R, Cremer T (1994) Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 144:1203-1218
12. Weber R, Sommer C, Albert F, Kiessling M, Cremer T (1996) Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. Lab Invest 74:108-119
13. Mao X, Hamoudi RA (2000) Molecular and cytogenetic analysis of glioblastoma multiforme. Cancer Genet Cytogenet 122:87-92
14. Maruno M, Yoshimine T, Ghulam Muhammad AKM, Ninomiya H, Kato A, Hayakawa T (1999) Chromosomal aberrations detected by comparative genomic hybridization (CGH) in human astrocytic tumors. Cancer Lett 135:61-66
15. Weber RG, Sabel M, Reifenberger J, Sommer C, Oberstrass J, Reifenberger G, Kiessling M, Cremer T (1996) Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13:983-994
16. Arslantas A, Artan S, Oner U, Durmaz R, Muslumanoglu MH, Atasoy MA, Basaran N, Tel E (2002) Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas. Acta Neurol Belg 102:53-62
17. Durmaz R, Erken S, Arslantas A, Atasoy MA, Bal C, Tel E (1997) Management of glioblastoma multiforme: with special reference to recurrence. Clin Neurol Neurosurg 99:117-123
18. Obwegeser A, Ortler M, Seiwald M, Ulmer H, Kostron H (1995) Therapy of glioblastoma multiforme. A cumulative experience of 10 years. Acta Neurochir (Wien) 137:29-33
19. Romeike BFM, Jung V, Feiden W, Moringlane JR, Zang KD, Urbschat SM (2001) Distribution of epidermal growth factor receptor protein correlates with gain in chromosome 7 revealed by comparative genomic hybridization after microdissection in glioblastoma multiforme. Pathol Res Pract 197:427-431
20. Schlegel J, Scherthan H, Arens N, Stumm G, Kiessling M (1996) Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization. J Neuropathol Exp Neurol 55:81-87
21. Sano T, Lin H, Chen X, Langford LA, Koul D, Bondy ML, Hess KR, Myers JN, Hong K, Yung WK, Steck PA (1999) Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res 59:1820-1824
22. Leenstra S, Bijlsma EK, Troost D, Oosting J, Wesrerveld A, Bosch DA, Hulsebos TJM (1994) Allele loss on chromosome 10 and 17p and epidermal growth factor receptor amplification in human malignant astrocytoma related to prognosis. Br J Cancer 70:684-689
23. Balesaria S, Brock C, Bower M, Clark J, Nicholson SK, Lewis P, de Sanctis S, Evans H, Peterson D, Mendoza N, Glaser MG, Newlands ES, Fisher RA (1999) Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas. Br J Cancer 81:1371-1377
24. Teich NM (1998) Oncogenes and cancer. In: Franks LM, Teich NM (eds) Cellular and molecular biology of cancer. Oxford University Press, NewYork, pp 169-201
25. Lang FF, Miller DC, Koslow M, Newcomb EW (1994) Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 81:427-436
26. Watanabe K, Tachibana O, Sato K, Yonekawa Y, Kleihues P, Ohgaki H (1996) Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6:217-223
27. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145:1175-1190
28. Bigner SH, Matthews MR, Rasheed BKA, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD (1999) Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol 155:375-386
29. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473-1479
30. Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN (2001) Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 7:839-845
31. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas and mixed oligoastrocytomas. J Clin Oncol 18:636-645